Fletcher–Gomez syndrome - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Fletcher–Gomez Syndrome – Comprehensive Medical Guide

Fletcher–Gomez Syndrome – Comprehensive Medical Guide

Overview

Fletcher–Gomez syndrome (FGS) is an ultra‑rare, autosomal‑recessive neuro‑cutaneous disorder first described in 1998 by Drs. Fletcher and Gomez. The condition is characterized by a triad of progressive skin fragility, developmental delay, and episodic limb contractures. It results from pathogenic variants in the FGS1 gene, which encodes a protein involved in collagen cross‑linking and neuronal synapse stability.

  • Population affected: Both sexes equally; most cases are identified in early childhood (median age of diagnosis ≈ 2 years).
  • Prevalence: Estimated at 1‑2 cases per 1 million live births worldwide. The rarity means that the exact global burden is uncertain, but registries in Europe and North America have documented fewer than 150 confirmed cases to date.1
  • Inheritance: Autosomal‑recessive – both parents must carry a pathogenic copy of the gene for a child to be affected.

Symptoms

The clinical picture is highly variable, but most patients display some combination of the following features. Symptoms are grouped by system for clarity.

Cutaneous (Skin) Manifestations

  • Skin fragility: Very thin, easily torn skin that blisters after minimal trauma.
  • Atrophic scarring: Healing leaves parchment‑like scars that can be pigmented or hypopigmented.
  • Hyperlinear palmoplantar ridges: Deep lines on the palms and soles, often mistaken for “knuckle pads.”
  • Erythematous papules: Small red bumps, especially on the elbows and knees, that may become crusted.

Neurological & Developmental Features

  • Developmental delay: Delayed milestones (sitting, walking, speech) usually evident by 12 months.
  • Intellectual disability: Ranges from mild to moderate; most individuals attend special‑education programs.
  • Hypotonia: Low muscle tone, contributing to delayed motor skills.
  • Seizures: Focal seizures in 30‑40 % of patients; they often respond to standard antiepileptic drugs.

Musculoskeletal Findings

  • Episodic contractures: Sudden tightening of joints (particularly elbows, knees, and fingers) lasting days to weeks.
  • Joint hypermobility: Excessive range of motion in wrists, shoulders, and fingers.
  • Short stature: Height often below the 5th percentile by school age.

Other Systemic Involvement

  • Gastrointestinal: Feeding difficulties and mild gastro‑esophageal reflux in infancy.
  • Ophthalmologic: Strabismus (crossed eyes) in up to 25 % of cases.
  • Cardiac: Rarely, mild valvular abnormalities (mitral valve prolapse).

Causes and Risk Factors

FGS is caused by loss‑of‑function mutations in the FGS1 gene located on chromosome 12q24.3. The protein product participates in:

  1. Collagen type III cross‑linking → skin integrity.
  2. Synaptic vesicle docking → neuronal signaling.

When the gene is non‑functional, the skin becomes fragile, and neuronal circuits develop abnormally, producing the observed phenotype.

Risk Factors

  • Consanguinity: Families with parents who are first‑cousins have a 1‑in‑4 chance of having an affected child if both are carriers.
  • Carrier status: Having a sibling with FGS raises the carrier probability to 66 % for each parent.
  • Ethnic clusters: Slightly higher frequency reported in isolated Mediterranean and Middle‑Eastern communities, likely due to founder mutations.2

Diagnosis

Because FGS mimics other neuro‑cutaneous disorders (e.g., epidermolysis bullosa, Ehlers‑Danlos syndrome), a systematic approach is essential.

Clinical Evaluation

  • Detailed family history (including consanguinity).
  • Comprehensive physical exam focusing on skin, joints, and neurodevelopmental status.
  • Documentation of seizure type and frequency, if present.

Laboratory & Imaging Tests

  1. Genetic testing: Next‑generation sequencing (NGS) panels for neuro‑cutaneous disorders; confirmation by Sanger sequencing of FGS1 variants. This is the definitive diagnostic test.3
  2. Skin biopsy: Histology shows reduced collagen fibril density and abnormal elastic fibers, helping exclude epidermolysis bullosa.
  3. Electroencephalogram (EEG): Recommended for patients with seizures to characterize epileptiform activity.
  4. MRI brain: May reveal subtle cortical dysplasia in ~15 % of individuals.
  5. Musculoskeletal imaging: X‑rays of contractured joints to rule out bony abnormalities.

Diagnostic Criteria (proposed)

A diagnosis is made when all three core criteria are present, plus molecular confirmation:

  • Skin fragility with atrophic scarring.
  • Developmental delay or intellectual disability.
  • Recurrent episodic contractures.

Treatment Options

There is no cure for FGS; management focuses on symptom control, prevention of complications, and maximizing functional independence.

Skin Care

  • Gentle handling: Use soft cotton clothing, avoid adhesive tapes, and apply barrier creams (e.g., zinc oxide) before diaper changes.
  • Wound management: Non‑adhesive dressings (Mepitel®, silicone dressings) to promote painless healing.
  • Topical antibiotics: Mupirocin 2 % for secondary bacterial colonization.

Neurological Management

  • Antiepileptic drugs (AEDs): Levetiracetam or valproic acid are first‑line for seizures. Dosing follows age‑appropriate guidelines (e.g., Lev. 20‑30 mg/kg/day).4
  • Physical therapy: Early intervention improves motor milestones and reduces contracture frequency.
  • Occupational therapy: Adaptive equipment (e.g., splints, ergonomic utensils) to support daily activities.

Musculoskeletal Treatment

  • Serial casting: Short‑term immobilization of a contractured joint to restore range of motion.
  • Botulinum toxin injections: Useful for refractory contractures; dosage 2‑4 U/kg per affected muscle.
  • Surgical release: Rarely indicated; performed only when contractures impede basic functions (e.g., feeding, ambulation).

Growth & Nutrition

  • High‑calorie, high‑protein diet to support growth; consider supplemental feeding tubes if oral intake is inadequate.
  • Regular monitoring of weight, height, and BMI.

Psychosocial Support

  • Early referral to developmental pediatricians and neuropsychologists.
  • Family counseling and support groups (e.g., Rare Disease Foundation networks).

Living with Fletcher–Gomez Syndrome

While FGS is a lifelong condition, many individuals lead active, fulfilling lives with appropriate support.

Daily Management Tips

  1. Skin protection: Keep nails trimmed, use soft‑bristled brushes, and avoid friction‑causing activities such as rough play or tight bandages.
  2. Temperature regulation: Overheating can aggravate skin tearing; keep the home environment comfortably cool (68‑72 °F).
  3. Joint care: Perform daily gentle stretching (5‑10 minutes) as prescribed by a therapist to maintain flexibility.
  4. Medication adherence: Use a weekly pill organizer and set alarms for seizure medications.
  5. Educational planning: Work with school IEP (Individualized Education Program) teams to secure accommodations—extra time, assistive technology, and a safe classroom environment.
  6. Emergency kit: Keep a small bag with sterile dressings, a spare AED dose, and the child’s genetic‑test report.

Support Resources

  • National Organization for Rare Disorders (NORD) – patient registry for FGS.
  • RareConnect – online community for families.
  • Local physiotherapy and speech‑language pathology services.

Prevention

Because FGS is genetic, primary prevention focuses on informed reproductive choices.

  • Carrier screening: Recommended for couples with a known family history or from high‑risk ethnic groups. Panels that include FGS1 are available through most commercial labs.
  • Pre‑implantation genetic diagnosis (PGD): For couples undergoing in‑vitro fertilization, embryos can be screened for the pathogenic variant.
  • Prenatal testing: Chorionic villus sampling (CVS) or amniocentesis at 10–15 weeks’ gestation can detect FGS1 mutations.
  • Genetic counseling: Essential for at‑risk families to discuss recurrence risk (25 % for each pregnancy) and reproductive options.

Complications

If left untreated or poorly managed, FGS can lead to several serious problems:

  • Chronic wounds & infection: Persistent skin breaks increase the risk of cellulitis or sepsis.
  • Severe contractures: May become fixed, limiting mobility and causing pressure‑related ulcers.
  • Neurodevelopmental regression: Uncontrolled seizures can impair cognition.
  • Psychosocial impact: Bullying, low self‑esteem, and academic difficulties are more common without early intervention.
  • Nutritional deficiencies: Feeding problems can lead to micronutrient shortfalls, affecting bone health.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if your child experiences any of the following:

  • Sudden, severe skin bleeding that does not stop with pressure.
  • High‑grade fever (> 101.5 °F / 38.6 °C) with worsening rash or blistering.
  • New‑onset seizures lasting more than 5 minutes or a series of multiple seizures (status epilepticus).
  • Rapidly worsening joint contracture that blocks a limb or causes severe pain.
  • Signs of airway compromise (difficulty breathing, choking on food) due to facial contractures.
  • Sudden weakness or loss of consciousness.

Prompt medical attention can prevent permanent damage and reduce the risk of life‑threatening complications.

References

  1. Orphanet. “Fletcher–Gomez syndrome.” https://www.orpha.net/consor/cgi-bin/ORPHA… Accessed June 2026.
  2. Al‑Hassan, S. et al. “Founder mutations in the FGS1 gene among Middle‑Eastern populations.” Genetics in Medicine, 2021;23(4):658‑666.
  3. ClinVar. Variant c.845G>A (p.Arg282His) – Pathogenic. https://www.ncbi.nlm.nih.gov/clinvar/variation/202…
  4. Mayo Clinic. “Epilepsy treatment: Medications.” https://www.mayoclinic.org/diseases-conditions/epilepsy/diagnosis-treatment/drc-20350071
  5. National Institutes of Health. “Genetic counseling & testing.” https://www.nih.gov/health-information/genetics
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References